Cargando…
Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method
BACKGROUND: The global pandemic of coronavirus disease 2019 (COVID-19) continues to affect people around the world, with one of the most frequent comorbidities being Type 2 Diabetes (T2D). Studies have suggested a link between disbalances in gut microbiota and these diseases, as well as with COVID-1...
Autores principales: | Petakh, Pavlo, Kobyliak, Nazarii, Kamyshnyi, Aleksandr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947359/ https://www.ncbi.nlm.nih.gov/pubmed/36844398 http://dx.doi.org/10.3389/fcimb.2023.1142578 |
Ejemplares similares
-
Effects of metformin on the gut microbiota: A systematic review
por: Pavlo Petakh, et al.
Publicado: (2023) -
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
por: Petakh, Pavlo, et al.
Publicado: (2023) -
Weil’s Disease—Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota
por: Petakh, Pavlo, et al.
Publicado: (2022) -
Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review
por: Petakh, Pavlo, et al.
Publicado: (2023) -
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
por: Petakh, Pavlo, et al.
Publicado: (2023)